Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants
Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning ...
Jul 1, 2021
0
180